ATE268765T1 - Indolderivate zum gebrauch in der behandlung von zns-störungen - Google Patents
Indolderivate zum gebrauch in der behandlung von zns-störungenInfo
- Publication number
- ATE268765T1 ATE268765T1 AT01940241T AT01940241T ATE268765T1 AT E268765 T1 ATE268765 T1 AT E268765T1 AT 01940241 T AT01940241 T AT 01940241T AT 01940241 T AT01940241 T AT 01940241T AT E268765 T1 ATE268765 T1 AT E268765T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- cns disorders
- indole derivatives
- indole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200001018 | 2000-06-29 | ||
PCT/DK2001/000407 WO2002000645A1 (en) | 2000-06-29 | 2001-06-13 | Indole derivatives useful for the treatment of cns disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE268765T1 true ATE268765T1 (de) | 2004-06-15 |
Family
ID=8159589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01940241T ATE268765T1 (de) | 2000-06-29 | 2001-06-13 | Indolderivate zum gebrauch in der behandlung von zns-störungen |
Country Status (23)
Country | Link |
---|---|
US (1) | US20030232822A1 (de) |
EP (1) | EP1299380B1 (de) |
JP (1) | JP2004501912A (de) |
KR (1) | KR20030011365A (de) |
CN (1) | CN1439004A (de) |
AR (1) | AR028736A1 (de) |
AT (1) | ATE268765T1 (de) |
AU (1) | AU2001273882A1 (de) |
BG (1) | BG107471A (de) |
BR (1) | BR0112286A (de) |
CA (1) | CA2414115A1 (de) |
CZ (1) | CZ20024192A3 (de) |
DE (1) | DE60103761D1 (de) |
EA (1) | EA200300084A1 (de) |
HU (1) | HUP0300786A2 (de) |
IL (1) | IL153254A0 (de) |
IS (1) | IS6642A (de) |
MX (1) | MXPA02012506A (de) |
NO (1) | NO20026029L (de) |
PL (1) | PL358966A1 (de) |
SK (1) | SK1092003A3 (de) |
WO (1) | WO2002000645A1 (de) |
ZA (1) | ZA200209886B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117577D0 (en) * | 2001-02-16 | 2001-09-12 | Aventis Pharm Prod Inc | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands |
AU2003257407A1 (en) * | 2002-08-29 | 2004-03-19 | H. Lundbeck A/S | S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
DE102004027358A1 (de) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidinverbindungen und ihre Verwendung |
AU2007281591A1 (en) | 2006-07-31 | 2008-02-07 | Janssen Pharmaceutica, N.V. | Urotensin II receptor antagonists |
SE531698C2 (sv) | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
FR2953839A1 (fr) * | 2009-12-14 | 2011-06-17 | Sanofi Aventis | Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL310443A1 (en) * | 1993-03-01 | 1995-12-11 | Merck Sharp & Dohme | Derivatives of pyrolo-pyridine |
ZA9711376B (en) * | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
-
2001
- 2001-06-13 IL IL15325401A patent/IL153254A0/xx unknown
- 2001-06-13 AT AT01940241T patent/ATE268765T1/de not_active IP Right Cessation
- 2001-06-13 JP JP2002505393A patent/JP2004501912A/ja not_active Withdrawn
- 2001-06-13 BR BR0112286-0A patent/BR0112286A/pt not_active Application Discontinuation
- 2001-06-13 MX MXPA02012506A patent/MXPA02012506A/es unknown
- 2001-06-13 AU AU2001273882A patent/AU2001273882A1/en not_active Abandoned
- 2001-06-13 WO PCT/DK2001/000407 patent/WO2002000645A1/en not_active Application Discontinuation
- 2001-06-13 KR KR1020027017614A patent/KR20030011365A/ko not_active Application Discontinuation
- 2001-06-13 HU HU0300786A patent/HUP0300786A2/hu unknown
- 2001-06-13 PL PL01358966A patent/PL358966A1/xx not_active Application Discontinuation
- 2001-06-13 CA CA002414115A patent/CA2414115A1/en not_active Abandoned
- 2001-06-13 CZ CZ20024192A patent/CZ20024192A3/cs unknown
- 2001-06-13 EP EP01940241A patent/EP1299380B1/de not_active Expired - Lifetime
- 2001-06-13 CN CN01811847A patent/CN1439004A/zh active Pending
- 2001-06-13 EA EA200300084A patent/EA200300084A1/ru unknown
- 2001-06-13 SK SK109-2003A patent/SK1092003A3/sk unknown
- 2001-06-13 DE DE60103761T patent/DE60103761D1/de not_active Expired - Fee Related
- 2001-06-19 AR ARP010102901A patent/AR028736A1/es unknown
-
2002
- 2002-11-29 IS IS6642A patent/IS6642A/is unknown
- 2002-12-05 ZA ZA200209886A patent/ZA200209886B/en unknown
- 2002-12-16 NO NO20026029A patent/NO20026029L/no not_active Application Discontinuation
- 2002-12-17 US US10/327,670 patent/US20030232822A1/en not_active Abandoned
-
2003
- 2003-01-17 BG BG107471A patent/BG107471A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA02012506A (es) | 2003-04-25 |
AR028736A1 (es) | 2003-05-21 |
CZ20024192A3 (cs) | 2003-04-16 |
IL153254A0 (en) | 2003-07-06 |
BG107471A (en) | 2003-10-31 |
IS6642A (is) | 2002-11-29 |
SK1092003A3 (en) | 2003-05-02 |
US20030232822A1 (en) | 2003-12-18 |
NO20026029D0 (no) | 2002-12-16 |
CA2414115A1 (en) | 2002-01-03 |
PL358966A1 (en) | 2004-08-23 |
EA200300084A1 (ru) | 2003-06-26 |
WO2002000645A1 (en) | 2002-01-03 |
EP1299380B1 (de) | 2004-06-09 |
ZA200209886B (en) | 2003-12-05 |
EP1299380A1 (de) | 2003-04-09 |
DE60103761D1 (de) | 2004-07-15 |
JP2004501912A (ja) | 2004-01-22 |
AU2001273882A1 (en) | 2002-01-08 |
NO20026029L (no) | 2002-12-16 |
KR20030011365A (ko) | 2003-02-07 |
BR0112286A (pt) | 2003-05-13 |
CN1439004A (zh) | 2003-08-27 |
HUP0300786A2 (hu) | 2003-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20020384D0 (no) | Amin og aminderivater som ligander for neuropeptid Y Y5 reseptor anvendelig ved behandling av fedme og andre forstyrrelser | |
NO20032801D0 (no) | Tiazolderivater for behandling av PPAR relaterte forstyrrelser | |
ATE269303T1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
NO20014047L (no) | Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser | |
DE60022867D1 (de) | 1-Arenesulfonyl-2-Aryl-Pyrrolidin und Piperidin Derivative zur Behandlung von CNS-Erkrankungen | |
DE60111379D1 (de) | Indolderivate zum gebrauch in der behandlung von zns-störungen | |
ATE268765T1 (de) | Indolderivate zum gebrauch in der behandlung von zns-störungen | |
ATE321040T1 (de) | 4-, 5-, 6- und 7-indolderivate die in der behandlung von störungen des cns benutzt werden können | |
NO20030127L (no) | Indolderivater nyttige for behandling av CNS-forstyrrelser | |
ATE262525T1 (de) | Indolderivate zur verwendung in der behandlung von zns-störungen | |
HK1059086A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
IL153351A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
SI1294710T1 (en) | Indole derivatives useful for the treatment of cns disorders | |
SI1305307T1 (en) | Indole derivatives useful for the treatment of cns disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |